Gadobutrol Injection
Product Images NDC 70436-214

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gadobutrol (NDC 70436-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of gadobutrol, showing the gadolinium ion (Gd3+) complexed with a multi-ring ligand containing nitrogen and oxygen atoms, along with several carboxylate and hydroxyl groups.*

FDA Label Image

7.5 Mmol Per 7.5 mL (Image 02)

Label for Gadobutrol Injection 7.5 mmol/7.5 mL (1 mmol/mL) intravenous solution, a sterile single-dose vial. The label includes dosing information, NDC 70436-212-32, and highlights discard of unused portion. Manufactured in China, distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio. Storage instructions and expiration area are noted.*

FDA Label Image

15 Mmol Per 15 mL (Image 03)

Label for Gadobutrol Injection, an intravenous injection with a concentration of 1 mmol/mL (15 mmol/15 mL) in a 15 mL single-dose vial. The label includes storage instructions for 20° to 25°C, manufacturer information from Hainan Poly Pharm Co., Ltd., and distribution details by Slate Run Pharmaceuticals, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.